Short-term menopausal hormone therapy (MHT ... At the end of four years, no cognitive benefit or harm was seen in those who received MHT compared to the placebo group. However, long-term cognitive ...
Andersen Endowed Professor in Women’s Health at the Mayo Clinic. The Kronos Early Estrogen Prevention Study (KEEPS) found no benefits or harms on cognition after four years of mHT for women in early ...
Similarly, a “normal” estrogen level ranges from 30 to 300, and there’s no data that says being closer to 30 or closer to 300 is better for you because every person reacts differently to ...
Short-term menopausal hormone therapy (MHT) did not have long-term cognitive effects when given to women in early postmenopause, according to a study published November 21 st in the open-access ...